Core Laboratories NV Cash Flow Conversion Efficiency
Core Laboratories NV cash flow conversion efficiency. Based on the latest financial reports, Core Laboratories NV (CLB) has a cash flow conversion efficiency ratio of 0.014x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($3.96 Million) by net assets ($275.14 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Core Laboratories NV for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Core Laboratories NV (1995–2025)
Cash flow conversion efficiency of Core Laboratories NV from 1995 to 2025. This chart illustrates how Core Laboratories NV's cash flow conversion efficiency has evolved over time, based on yearly financial data. View CLB share price today for real-time trading data and today's change.
Core Laboratories NV Cash Flow Conversion Ratio Explained
Core Laboratories NV cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Core Laboratories NV Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Core Laboratories NV ranked by their cash flow conversion efficiency. Review how much free cash does Core Laboratories NV generate to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhejiang Yuejian Intelligent Equipment Co Ltd
SHG:603095
|
0.028x |
|
AMERISAFE Inc
NASDAQ:AMSF
|
-0.011x |
|
Korea Investment Holdings Co Ltd
KO:071055
|
-0.185x |
|
Yantai Longyuan Power Tech
SHE:300105
|
0.094x |
|
Beijing Jingyeda Technology Co Ltd
SHE:003005
|
-0.012x |
|
Shanghai Rongtai Health Tech
SHG:603579
|
-0.007x |
|
Berry Genomics Co Ltd
SHE:000710
|
-0.001x |
|
Waterdrop Inc ADR
NYSE:WDH
|
-0.010x |
Annual Cash Flow Conversion Efficiency for Core Laboratories NV (1995–2025)
The table below shows the annual cash flow conversion efficiency of Core Laboratories NV from 1995 to 2025. Also see CLB asset base for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $279.76 Million | $37.18 Million | 0.133x | -39.26% |
| 2024-12-31 | $257.74 Million | $56.39 Million | 0.219x | +102.82% |
| 2023-12-31 | $229.81 Million | $24.79 Million | 0.108x | -18.33% |
| 2022-12-31 | $188.95 Million | $24.96 Million | 0.132x | -41.87% |
| 2021-12-31 | $161.00 Million | $36.58 Million | 0.227x | -70.33% |
| 2020-12-31 | $75.57 Million | $57.87 Million | 0.766x | +55.78% |
| 2019-12-31 | $182.14 Million | $89.53 Million | 0.492x | -29.28% |
| 2018-12-31 | $160.90 Million | $111.83 Million | 0.695x | -16.82% |
| 2017-12-31 | $148.73 Million | $124.27 Million | 0.836x | -1.62% |
| 2016-12-31 | $155.30 Million | $131.89 Million | 0.849x | +109.19% |
| 2015-12-31 | $-23.70 Million | $219.10 Million | -9.245x | -386.37% |
| 2014-12-31 | $93.99 Million | $303.45 Million | 3.228x | +83.43% |
| 2013-12-31 | $169.39 Million | $298.14 Million | 1.760x | +39.43% |
| 2012-12-31 | $187.91 Million | $237.20 Million | 1.262x | +12.33% |
| 2011-12-31 | $181.66 Million | $204.13 Million | 1.124x | +59.60% |
| 2010-12-31 | $292.34 Million | $205.83 Million | 0.704x | +9.08% |
| 2009-12-31 | $281.76 Million | $181.87 Million | 0.645x | -33.33% |
| 2008-12-31 | $160.31 Million | $155.21 Million | 0.968x | -50.99% |
| 2007-12-31 | $63.63 Million | $125.69 Million | 1.975x | +20.33% |
| 2006-12-31 | $73.28 Million | $120.31 Million | 1.642x | +372.72% |
| 2005-12-31 | $215.32 Million | $74.78 Million | 0.347x | +22.63% |
| 2004-12-31 | $191.37 Million | $54.20 Million | 0.283x | +3.03% |
| 2003-12-31 | $221.48 Million | $60.88 Million | 0.275x | +73.37% |
| 2002-12-31 | $258.49 Million | $40.98 Million | 0.159x | +54.76% |
| 2001-12-31 | $276.42 Million | $28.32 Million | 0.102x | +257.71% |
| 2000-12-31 | $253.75 Million | $7.27 Million | 0.029x | +33.78% |
| 1999-12-31 | $210.20 Million | $4.50 Million | 0.021x | -35.74% |
| 1998-12-31 | $198.10 Million | $6.60 Million | 0.033x | +302.18% |
| 1997-12-31 | $115.30 Million | $-1.90 Million | -0.016x | -108.91% |
| 1996-12-31 | $47.60 Million | $8.80 Million | 0.185x | -10.68% |
| 1995-12-31 | $37.20 Million | $7.70 Million | 0.207x | -- |
About Core Laboratories NV
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and … Read more